Company Overview
Snapshot
Founded in January 2025 by Rami Verbin and Shay Shilo, Kulmus Genetics operates with 1–10 employees. The company has raised $50,000 across one funding round, focusing on advancing DNA synthesis technologies.
Business overview
Kulmus Genetics is developing a high-throughput DNA synthesis solution for the rapidly expanding synthetic biology field. The company's core technology aims to revolutionize synthetic DNA production, which is crucial for various synthetic biology applications. Operating within the Health Tech & Life Sciences sector, Kulmus Genetics serves markets including Healthcare & Life Sciences and Agriculture & Food.
Log in to access full profile ›Company Intelligence Q&A
- When was Kulmus Genetics founded?
- Kulmus Genetics was founded in January 2025.
- Who are the founders of Kulmus Genetics?
- Kulmus Genetics was founded by Rami Verbin and Shay Shilo, who both serve as co-CEOs.
- What is Kulmus Genetics' primary focus?
- Kulmus Genetics is focused on revolutionizing DNA synthesis by developing a high-throughput solution for the synthetic biology field.
- How much capital has Kulmus Genetics raised to date?
- Kulmus Genetics has raised a total of $50,000 across one funding round.
- In which sectors does Kulmus Genetics operate?
- Kulmus Genetics operates in the Health Tech & Life Sciences sector, with core technologies in Platforms & Interfaces, Biologicals, and Materials & Substances.